Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1975 Jun 14;112(13 Spec No):63–66.

Synergy of trimethoprim-sulfamethoxazole.

S R Bushby
PMCID: PMC1956440  PMID: 1093654

Full text

PDF
63S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. D., Lacey R. W., Lewis E. L., Sellin M. A. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. J Clin Pathol. 1974 Aug;27(8):619–622. doi: 10.1136/jcp.27.8.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Angehrn P., Then R. Nature of trimethoprim-induced death in Escherichia coli. Arzneimittelforschung. 1973 Mar;23(3):447–451. [PubMed] [Google Scholar]
  3. BROWN G. M. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem. 1962 Feb;237:536–540. [PubMed] [Google Scholar]
  4. Barker J., Healing D., Hutchison J. G. Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. J Clin Pathol. 1972 Dec;25(12):1086–1088. doi: 10.1136/jcp.25.12.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burchall J. J., Hitchings G. H. Inhibitor binding analysis of dihydrofolate reductases from various species. Mol Pharmacol. 1965 Sep;1(2):126–136. [PubMed] [Google Scholar]
  6. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bushby S. R. Sensitivity testing with trimethorpim-sulphamethoxazole. Med J Aust. 1973 Jun 30;1(2 Suppl):10–18. [PubMed] [Google Scholar]
  8. Bushby S. R. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973 Nov;128(Suppl):442–p. doi: 10.1093/infdis/128.supplement_3.s442. [DOI] [PubMed] [Google Scholar]
  9. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fruensgaard K., Korner B. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections. Chemotherapy. 1974;20(2):97–101. doi: 10.1159/000221797. [DOI] [PubMed] [Google Scholar]
  11. Hitchings G. H. Folate antagonists as antibacterial and antiprotozoal agents. Ann N Y Acad Sci. 1971 Nov 30;186:444–451. doi: 10.1111/j.1749-6632.1971.tb31171.x. [DOI] [PubMed] [Google Scholar]
  12. Hunter I. J. Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections. Med J Aust. 1972 Feb 26;1(9):442–442. [PubMed] [Google Scholar]
  13. Jobanputra R. S., Datta N. Trimethoprim R factors in enterobacteria from clinical specimens. J Med Microbiol. 1974 May;7(2):169–177. doi: 10.1099/00222615-7-2-169. [DOI] [PubMed] [Google Scholar]
  14. Koch A. E., Burchall J. J. Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol. 1971 Nov;22(5):812–817. doi: 10.1128/am.22.5.812-817.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lebek G. Extrachromosomale, übertragbare Antibiotika-resistenz bei Krankheitserregern des Menschen. Hippokrates. 1972 Mar;43(1):45–60. [PubMed] [Google Scholar]
  16. Lewis E. L., Lacey R. W. Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis. J Clin Pathol. 1973 Mar;26(3):175–180. doi: 10.1136/jcp.26.3.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nakhla L. S. Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim. J Clin Pathol. 1972 Aug;25(8):708–712. doi: 10.1136/jcp.25.8.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. ROTH B., FALCO E. A., HITCHINGS G. H., BUSHBY S. R. 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO. J Med Pharm Chem. 1962 Nov;91:1103–1123. doi: 10.1021/jm01241a004. [DOI] [PubMed] [Google Scholar]
  19. STACEY K. A., SIMSON E. IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI. J Bacteriol. 1965 Aug;90:554–555. doi: 10.1128/jb.90.2.554-555.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Then R., Angehrn P. The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo--I. Action of sulfonamides and trimethoprim in blood and urine. Biochem Pharmacol. 1974 Nov 1;23(21):2977–2982. doi: 10.1016/0006-2952(74)90272-x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES